PRO MEDICUS LIMITED — Board/Management Information 2007

Aug 29, 2007

Attention ASX Company Announcements Platform Lodgement of Open Briefing®

Pro Medicus Limited 450 Swan Street Richmond, Victoria 3121

Date of lodgement: 30-Aug-2007

Title: Open Briefing® . Pro Medicus. CEO on Management Succession

Record of interview:

corporatefile.com.au

Pro Medicus Limited today announced the appointment of David Chambers as its new CEO and announced that you would move to the role of Deputy Chairman and remain as an Executive Director. Why have you decided to step down as CEO and why at this time?

CEO Sam Hupert

During my time as CEO we've built up the company to a point where we now have an excellent foundation for growth, both here in Australia in digital imaging and in North America, particularly the US, where we have huge potential. But, we think we need a wider management skill set to build on that foundation and really maximise that potential.

To us, it seems like perfect timing. The company's in the best possible shape; we've just announced our biggest ever profit and have the foundation in place for a step-change in our growth. We also knew David was coming back to Australia at the end of his Agfa contract; we know David well and believed he would be ideally suited to the role.

corporatefile.com.au

What will your new role entail and what level of involvement will you retain in the day-to-day running of the company?

CEO Sam Hupert

I'll retain a significant day-to-day role. I'll continue to focus on areas where I believe I have strengths – being a doctor is a very significant advantage in a medically oriented business like ours. I know the markets well, particularly here in Australia, where we've been dealing with radiologists and other medical practitioners for up to 20 years. I've also had an integral role in product development, where my medical background gives me an understanding of what doctors are looking for.

I'll also continue to have responsibility for strategy in relation to our US roll-out and other growth opportunities.

With David coming on board we're bolstering our management and strategic capability by having two highly complementary sets of skills. David brings us his significant international commercial experience, particularly in the key markets that we need to work in like the US. We believe the combination of our skills and experience gives us the best possible management mix.

corporatefile.com.au

Why was David chosen and when will he join the company?

CEO Sam Hupert

It's the board's view that David has an ideal set of skills for us. He's been in the healthcare industry and in particular the diagnostic imaging sector, the mainstay of Agfa's healthcare business, for many years. He's extremely well connected in the industry here in Australia, where he was General Manager of Agfa HealthCare Australia and a Director of Agfa Australia, and in the US, where he headed Agfa HealthCare Sales and Marketing and more recently its Services organisation as well.

Also, we've worked very closely with David over the years. He was instrumental in our original deal with Agfa in Australia back in 2001 and was supportive of our move to the US.

As for timing, it's not finally decided when David will join us, but it's likely to be the beginning of December at the latest.

corporatefile.com.au

What will be the transition process?

CEO Sam Hupert

The board is keen that there's a defined hand-over process, and that needs to be discussed with David before it's finalised. That said, David and I will be working very closely together and because of our complementary skills I'd expect the transition to be fairly seamless.

corporatefile.com.au

Can you comment on the incentive component of David's remuneration package and the extent to which it's linked to growth in shareholder value? What level of growth does the board believe is achievable?

CEO Sam Hupert

A significant proportion of David's package will be performance-based and aligned to key metrics such as EPS growth and share price accretion, although those will be by no means the only metrics. And certainly some of his incentives will be in the form of equity so that his interests are aligned with shareholders'. That suits our company, the board and certainly David's aspirations.

We can't be specific about the level of growth we expect going forward other than to say that with David as CEO, enhancing our existing management skill set, we're expecting a step change.

corporatefile.com.au

When David joins the board, Pro Medicus will have three executive and three nonexecutive directors. How will you seek to ensure board independence?

CEO Sam Hupert

We feel that having three non-executives and three executives is not unbalanced. However it's something that we, as a board, will look at. Certainly having a strong, independent, non-executive chairman, which we have in Mel Ward, is an important factor in ensuring board independence.

corporatefile.com.au

In March 2006, you and Anthony Hall, the other founder and equal major shareholder in the company, each sold down your shareholdings to 30 percent of shares on issue from 40 percent. What is your intention with regard to your remaining 30 percent stake and will Anthony retain his stake and remain in his current executive and board roles?

CEO Sam Hupert

Anthony will definitely be staying in his executive and board roles and will be retaining his 30 percent share of the company. He's keen to drive some of the new developments we're currently pursuing. And certainly my intention is to keep my current stake in the company. Both Anthony and I believe there's going to be significant shareholder value growth ahead and we're looking forward to participating in that at the operational level and as shareholders.

corporatefile.com.au

Thank you Sam.

For more information about Pro Medicus, visit www.promedicus.com.au or call Sam Hupert on (+61 3) 9429 8800

For previous Open Briefings by Pro Medicus, or to receive future Open Briefings by e-mail, visit www.corporatefile.com.au

DISCLAIMER: Corporate File Pty Ltd has taken reasonable care in publishing the information contained in this Open Briefing®. It is information given in a summary form and does not purport to be complete. The information contained is not intended to be used as the basis for making any investment decision and you are solely responsible for any use you choose to make of the information. We strongly advise that you seek independent professional advice before making any investment decisions. Corporate File Pty Ltd is not responsible for any consequences of the use you make of the information, including any loss or damage you or a third party might suffer as a result of that use.